concept

BLOOD-BRAIN BARRIER DYSFUNCTION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about BLOOD-BRAIN BARRIER DYSFUNCTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

259Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

BLOOD-BRAIN BARRIER DYSFUNCTION is a concept in neurodegeneration research. Key relationships include: activates, contributes to, associated with. Associated with ALS, Aging, Als. Connected to 110 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	BLOOD-BRAIN BARRIER DYSFUNCTION
Category	evidence:strong
Summary	Page for Blood-Brain Barrier Dysfunction in Neurodegeneration
Key Genes/Proteins	ALS, ALZHEIMER'S DISEASE, ALZHEIMER
Related Diseases	Diabetes, Alzheimer, Inflammation, Neuroinflammation, NEUROINFLAMMATION
Related Pathways	Blood-Brain Barrier

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Pathway Diagram

graph TD
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO["BLOOD-BRAIN BARRIER DYSFUNCTION"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"activates"| sepsis_associated_encephalopat["sepsis-associated encephalopathy"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Diabetes["Diabetes"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Aging["Aging"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"regulates"| Stroke["Stroke"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Als["Als"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Ischemia["Ischemia"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"inhibits"| Ms["Ms"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"contributes to"| Alzheimer["Alzheimer"]
    BLOOD_BRAIN_BARRIER_DYSFUNCTIO -->|"contributes to"| ALS["ALS"]
    pericyte_senescence["pericyte senescence"] -->|"causes"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    pro_inflammatory_cytokines["pro-inflammatory cytokines"] -->|"activates"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    Amyloid__["Amyloid beta"] -->|"causes"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    SMAD2["SMAD2"] -->|"inhibits"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    AMYLOID["AMYLOID"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    TAU_PATHOLOGY["TAU PATHOLOGY"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    ALZHEIMER["ALZHEIMER"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO
    AND["AND"] -->|"contributes to"| BLOOD_BRAIN_BARRIER_DYSFUNCTIO

Outgoing (157)

Target	Relation	Type	Str
Alzheimer's Disease	associated_with	disease	0.95
Amyloid-β Accumulation	contributes_to	mechanism	0.93
Amyloid-β Accumulation	causes	process	0.90
Alzheimer's Disease	contributes_to	disease	0.90
peripheral immune cell infiltration	promotes	process	0.88
Radiation-Induced Brain Injury	contributes_to	disease	0.85
Neuroinflammatory Response	promotes	process	0.85
Cognitive Decline	contributes_to	phenotype	0.85
Neurodegeneration	contributes_to	disease	0.85
Stroke	associated_with	disease	0.85
Neuroinflammation	contributes_to	process	0.85
Biomarker For Cognitive Decline	biomarker_for	biomarker	0.82
Neurologic Diseases	contributes_to	disease	0.80
Gray Matter Atrophy	associated_with	phenotype	0.80
Hemorrhagic Transformation	contributes_to	phenotype	0.80
Cns Disorders	associated_with	disease	0.80
Alzheimer's Disease	biomarker_for	disease	0.80
Cognitive Decline	biomarker_for	phenotype	0.80
Alzheimer's Disease	involved_in	disease	0.80
Blood-Brain Barrier	activates	pathway	0.80
Biomarker For Neurodegeneration	biomarker_for	biomarker	0.75
Diabetes	inhibits	disease	0.75
Alzheimer	activates	disease	0.75
Inflammation	associated_with	disease	0.75
Neuroinflammation	associated_with	disease	0.75
Alzheimer'S Disease	contributes_to	disease	0.75
sepsis-associated encephalopathy	activates	disease	0.70
neuroinflammation	associated_with	process	0.70
radiation-induced brain injury	associated_with	disease	0.70
ALS	associated_with	gene	0.70
Blood-Brain Barrier	associated_with	pathway	0.70
ALZHEIMER'S DISEASE	activates	gene	0.70
ALZHEIMER	activates	gene	0.70
NEUROINFLAMMATION	inhibits	phenotype	0.70
NEURODEGENERATION	treats	phenotype	0.70
Stroke	associated_with	disease	0.65
Ms	associated_with	disease	0.65
Aging	inhibits	disease	0.65
Stroke	regulates	disease	0.65
Als	inhibits	disease	0.65
Ischemia	inhibits	disease	0.65
Ms	inhibits	disease	0.65
Aging	contributes_to	disease	0.65
Alzheimer	contributes_to	disease	0.65
ALS	contributes_to	disease	0.65
Huntington	contributes_to	disease	0.65
Dementia	contributes_to	disease	0.65
ALS	activates	disease	0.65
Stroke	activates	disease	0.65
Ischemia	therapeutic_target	disease	0.65

Incoming (102)

Source	Relation	Type	Str
APOE4	causes	gene	0.95
TNF	causes	protein	0.95
APOE	causes	gene	0.92
APOE	drives	gene	0.92
KCNK2	regulates	gene	0.90
APOE	mediates	gene	0.90
GRP78 Autoantibodies	mediates	biomarker	0.90
Neurovascular Unit Disruption	causes	process	0.90
Pericyte Senescence	causes	phenotype	0.90
APOE	promotes	gene	0.90
APOE4	mediates	gene	0.90
25-Hydroxycholesterol	protects_against	compound	0.90
KCNK2	contributes_to	gene	0.90
Uremic Toxins	contributes_to	compound	0.85
Cerebral Amyloid Angiopathy	associated_with	disease	0.85
Endothelium Dysfunction	causes	mechanism	0.85
Neurovascular Unit Dysfunction	causes	mechanism	0.85
GRP78 Autoantibodies	causes	biomarker	0.85
USP13	associated_with	gene	0.85
USP25	associated_with	gene	0.85
CYLD	associated_with	gene	0.85
macromolecule permeability	associated_with	phenotype	0.85
Alzheimer Disease	associated_with	disease	0.85
Vascular Dementia	associated_with	disease	0.85
Neuroinflammation	promotes	process	0.85
Normal Aging	causes	process	0.80
Neurovascular Coupling	associated_with	process	0.80
Hydrogel Models	targets	process	0.80
GFAP	associated_with	gene	0.80
VPS35 Dysregulation	contributes_to	mechanism	0.80
Senescent endothelial cells	contributes_to	cell_type	0.80
Neuroinflammation	mediates	process	0.80
RAS	modulates	pathway	0.80
Uremic Toxins	causes	compound	0.75
Advanced Glycation End Products	contributes_to	compound	0.75
MMP	mediates	protein	0.75
USP13	associated_with	gene	0.75
pericyte senescence	causes	process	0.70
neuroinflammation	associated_with	process	0.70
pro-inflammatory cytokines	activates	protein	0.70
Amyloid β	causes	protein	0.70
BRCC3	contributes_to	gene	0.70
NEUROINFLAMMATION	exacerbates	phenotype	0.70
amyloid-beta	contributes_to	protein	0.60
APOE	associated_with	gene	0.60
APP	associated_with	gene	0.60
CLU	associated_with	gene	0.60
SMAD2	inhibits	gene	0.60
AMYLOID	contributes_to	gene	0.60
ALZHEIMER'S DISEASE	contributes_to	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

BLOOD-BRAIN BARRIER DYSFUNCTION

Understanding Entity Pages

Summary

Wiki Pages (21)